Corona-Meraz Fernanda Isadora, Quintero-Castillo Blanca Perla, Hernández-Palma Luis Alexis, Machado-Sulbaran Andrea Carolina
Departamento de Ciencias Biomédicas, Centro Universitario de Tonalá, Universidad de Guadalajara, Guadalajara, México.
Unidad de Especialidades, Clínica Ambulatoria, Guadalajara, México.
Clin Ther. 2023 Sep;45(9):e187-e192. doi: 10.1016/j.clinthera.2023.06.026. Epub 2023 Jul 29.
To describe a case report of a patient with symptoms associated with metabolic alterations 1 month after having COVID-19.
Laboratory tests, clinical evaluations, and body composition assessments were performed by specialists.
The patient presented excessive sweating, hot flashes, dizziness, blurred vision, and seizure. Laboratory tests indicated low glucose levels after convulsions (50, 42.7, and 55 mg/dL), high insulin levels (basal, 638 µIU/mL; 2-hour, >1000 µU/mL), and positivity for anti-insulin antibodies. The patient was diagnosed with insulin autoimmune syndrome. Treatment with azathioprine and nutritional recommendations improved remission.
SARS-CoV-2 infection or vaccination might induce insulin tolerance failure.